
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 913 | 913 | 1122 | 1659 | 3356 | 3498 |
Fund Return | -8.69% | -8.69% | 12.22% | 18.38% | 27.4% | 13.34% |
Place in category | 52 | 52 | 75 | 42 | 35 | 7 |
% in Category | 61 | 61 | 85 | 48 | 61 | 27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Small Cap Fund Bonus | 508.26B | -14.18 | 20.68 | 20.04 | ||
Reliance Small Cap Fund Dividend | 508.26B | -14.80 | 19.86 | 20.27 | ||
Reliance Small Cap Fund Growth | 508.26B | -14.18 | 20.68 | 20.04 | ||
Reliance Small Cap Fund Dir Bon | 508.26B | -14.03 | 21.69 | 21.19 | ||
Reliance Small Cap Fund Dir Gr | 508.26B | -14.56 | 21.03 | 21.42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Pharma Fund - Bonus | 76.37B | -8.69 | 18.38 | 13.34 | ||
Reliance Pharma Dividend Payout | 76.37B | -9.44 | 17.76 | 14.28 | ||
Reliance Pharma Direct Bonus | 76.37B | -8.49 | 19.44 | 14.35 | ||
Reliance Pharma Direct Growth | 76.37B | -8.49 | 19.44 | 14.35 | ||
Reliance Pharma Dir Div Payout | 76.37B | -9.15 | 18.99 | 15.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.68 | 1,687.55 | +2.14% | |
Divi's Labs | INE361B01024 | 9.32 | 5,589.30 | +3.77% | |
Lupin | INE326A01037 | 7.73 | 1,969.25 | +2.58% | |
Cipla | INE059A01026 | 5.90 | 1,463.05 | +3.35% | |
Dr Reddy’s Laboratories | INE089A01031 | 5.35 | 1,109.50 | +1.41% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review